Bassler Bonnie L

CIK 00016836074 companiesTARRYTOWN, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001683607

Recent Transactions

50 trades

Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−11,100→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−16,000→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-07$374.12/sh+1,500→ 3,203 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Common Stock
2026-01-07$221.50/sh−15→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−1,400→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−875→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2026-01-07−1,500→ 2,861 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−1,750→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-07$800.00/sh−1,500→ 1,703 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-02+155→ 1,703 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2026-01-02+1,962→ 1,962 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-31$38.74/sh+967→ 73,132 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-11-20$371.40/sh+760→ 2,308 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-11-20$750.00/sh−760→ 1,548 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-11-20−760→ 756 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-09-30$35.79/sh+1,047→ 72,165 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-06-30$35.24/sh+1,064→ 71,118 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-13+7,614→ 70,054 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-03-31$32.87/sh+1,141→ 62,440 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-01-02+166→ 1,548 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-01-02+1,958→ 1,958 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-12-31$24.94/sh+1,503→ 61,299 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-12-17+16,000→ 16,000 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-09-30$27.92/sh+1,342→ 59,796 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-15$1170.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-08-15−756→ 1,516 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-15$371.40/sh+756→ 2,138 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-08-02−756→ 2,272 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-02$1115.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-02$371.40/sh+756→ 2,138 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-28$26.80/sh+1,399→ 58,454 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-06-24−756→ 3,028 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-24$1062.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-24$371.40/sh+756→ 2,138 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-07+9,293→ 57,055 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-06-05−827→ 0 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-05$1011.00/sh−827→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-05$380.95/sh+827→ 2,209 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-03-28$30.23/sh+1,240→ 47,762 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$979.25/sh−854→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-26−854→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$391.92/sh+854→ 2,236 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-30$380.95/sh+827→ 2,209 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-30−827→ 827 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-30$959.00/sh−827→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-03$380.95/sh+826→ 2,208 total

Companies

Recent Filings

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591

View on SEC.gov